Abstract
“Two reasons,” says Anthony Johnson, founder and CEO of the biotech start-up Kodikaz Therapeutic Solutions about the decision to launch his company at an incubator in Lower Manhattan. “We knew we wanted to set up in New York City because of the burgeoning biotech scene and all of the infrastructure in place for biotech to be a success,” he says. “Also, we were the inaugural Golden Ticket winner.” That Golden Ticket was issued in 2020 by BioLabs at NYU Langone, the incubator offering Kodikaz free rent for a year. The award was sponsored by the big drug firm Boehringer Ingelheim. With technology from Emory University, Kodikaz is working on a system for delivering cell and gene therapy with DNA fragments. Called Zip-Code, the platform enables targeted delivery of a wider variety of payloads than can be achieved using viruses and other standard delivery methods, the firm says. Kodikaz—the name derives
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
